Compliances Certificate under Reg.74 (5) of SEBI.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Transgene Biotek has submitted a quarterly compliance certificate to BSE under SEBI Regulation 74(5), which deals with depository-related disclosures. The certificate was issued by the company's Registrar and Share Transfer Agent, Bigshare Services Private Limited, on 14 July 2025. It covers the period from 1 April 2025 to 30 June 2025 (Q1 FY26) and confirms the details of shares dematerialized or rematerialized through NSDL and CDSL. The RTA has confirmed that no dematerialization or rematerialization requests were received during this quarter. The communication is signed by Managing Director Dr K Koteswara Rao.
This is a routine, administrative compliance filing with no material impact on shareholders or the stock price. It merely fulfils a quarterly regulatory obligation regarding share transfer activities, with no corporate action or financial implication.